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180 The Journal of Thoracic and CardioObjective: Despite the clinical importance of early graft dysfunction, no standard-
ized definition is available. We hypothesized that the arterial blood gas oxygen
tension/fraction of inspired oxygen ratio (PaO2/FIO2) would prove to be a useful
marker for predicting subsequent outcomes of early graft dysfunction. The aims of
this study were to define the prevalence of various ranges of PaO2/FIO2 over the first
48 hours after lung transplantation and to evaluate which measurement using the
PaO2/FIO2 best correlates with the duration of intubation, the length of stay in the
intensive care unit, and 30-day mortality, which are important alternative indicators
of early graft performance.
Methods: A retrospective study was performed that included all 68 bilateral single-
lung transplantations at The Alfred Hospital from January 2000 to December 2002.
Results: PaO2/FIO2 at 6 and 12 hours after admission to the intensive care unit was
significantly associated with the duration of intubation (r  0.44; P  .001 and
r  0.48; P  .001, respectively), and PaO2/FIO2 at 6 and 24 hours was also
significantly associated with the length of intensive care unit stay (r  0.38; P 
.002 and r  0.44; P  .001, respectively). Thirty-day mortality was significantly
associated with a lower PaO2/FIO2 at 6 hours (219  93 vs 306  101; P  .03).
Conclusions: PaO2/FIO2 taken between 6 and 12 hours after transplantation is a
useful marker associated with lung transplantation outcomes. There is the potential
for therapeutic interventions during this time that may be able to enhance PaO2/FIO2
by 12 hours and improve subsequent outcomes.
Lung transplantation has become an accepted therapeutic option for end-stagepulmonary disease and has resulted in remarkable overall improvements inoutcome.1 However, despite advances in organ preservation, surgical techniques,
and perioperative care, early mortality after lung transplantation remains notable. Ac-
cording to the 2003 Registry of the International Society for Heart and Lung Trans-
plantation, 41% of 1-year deaths occur within 30 days of transplantation. Early graft
dysfunction is one of the leading causes of this 30-day mortality, in turn, accounting for
30.5% of deaths in this time period.2 Early graft dysfunction encompasses other terms,
such as primary graft failure, pulmonary reimplantation response, and reperfusion
edema, and is clinically recognized as a impaired gas exchange, opacification of the
chest radiograph, and increased pulmonary vascular resistance within 24 hours of
transplantation.3-7 Whatever the original stimulus, this syndrome results in the require-
ment for prolonged mechanical ventilatory support with high levels of inspired oxygen
and a prolonged stay in the intensive care unit (ICU).3-9
Despite the clinical importance of early graft dysfunction, no standardized
definition or scoring system is available to assess its severity and to predict its
outcome.3-9 A standardized definition of early graft dysfunction enables us to grade
the severity of the graft function and also to create a standardized therapeutic
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ing early morbidity and mortality and their associated costs.
There are also advantages for the evaluation of management
strategies for donors and recipients and comparison between
centers.
The arterial blood gas oxygen tension/inspired oxygen frac-
tion ratio (PaO2/FIO2) is a simple marker widely used to assess
the graft function in lung transplantation3-9 and to define adult
respiratory distress syndrome.10 We hypothesized that PaO2/
FIO2 would prove to be a useful marker associated with sub-
sequent early outcomes in the definition of early graft dysfunc-
tion after lung transplantation. The aims of this study were to
define the prevalence of various ranges of PaO2/FIO2 over the
first 48 hours after lung transplantation and to evaluate which
measurement using PaO2/FIO2 best correlates with the duration
of intubation, the length of the ICU stay, and 30-day survival,
which are important alternative indicators of early graft
performance.
Methods
A retrospective study was performed that included all bilateral single-
lung transplantation procedures at The Alfred Hospital from January
2000 to December 2002. Heart-lung and single lung transplantations
were excluded from further analysis to avoid any confusion related to
the variable effects of the transplanted heart on cardiac pulmonary
edema or the residual native lung on hyperinflation.
Transplantation Protocol
Donor assessment, recipient selection, donor/recipient matching,
surgical technique, and postoperative management proceeded ac-
cording to our standard protocol, which has been described else-
where.11-14 Although lung donor selection criteria are based on
standard criteria, extended donors are commonly considered at our
institution.15 In some of these cases, the donor chest radiograph
may be abnormal, secretions may be purulent on bronchoscopy,
and the donor PaO2/FIO2 may be less than 300 mm Hg.
Preoperative immunologic evaluation was routinely performed.
The presence of preformed antibodies to human leukocyte antigen
was screened with a panel-reactive antibody assay, and all trans-
plant recipients were found to have values less than 10%. A
prospective donor/recipient T-cell and B-cell cross-match was
performed in all cases.
Lung procurement and preservation followed standard procedures
with cold-modified Euro-Collins solution for antegrade flushing.
However, we infused prostacyclin (Flolan) at 40 to 80 ng · kg1 ·
min1 intravenously for approximately 10 minutes before
crossclamp.
Postoperative management in the ICU was performed to ensure
satisfactory end-organ perfusion while maintaining a relatively
low filling pressure (cardiac index, 2.4; pulmonary capillary
wedge pressure, 10 mm Hg; and central venous pressure,
7 mm Hg). Patients with severe early graft dysfunction received
a standardized evaluation and therapy with increasing complexity
depending on the degree of ventilatory and hemodynamic com-
promise. Transesophageal echocardiography was performed to
exclude lung torsion and pulmonary vascular obstruction, and a
The Journal of Thoraciretrospective cross-match was performed to exclude humoral re-
jection. Therapy included pressure-controlled mechanical ventila-
tion, limitation of positive end-expiratory pressure to 12 to 15 cm
H2O, negative fluid balance with furosemide or continuous veno-
venous hemofiltration, inhaled nitric oxide 5 to 20 ppm, and
elevation of the upper body or lateral positioning if appropriate. If
these approaches failed, then extracorporeal membrane oxygen-
ation was considered.14
Immunosuppression was based on triple therapy with cyclosporine
(trough levels of 300-450 g/L), azathioprine (1.5-2.0 mg · kg1 ·
d1), and prednisolone (0.15 mg · kg1 · d1). Prophylaxis for
Pneumocystis carinii and cytomegalovirus infection was achieved
with low-dose oral trimethaprim-sulfamethoxazole and intravenous
ganciclovir, respectively.
Data Collection
All of the recipient data were collected from review of medical
records. Best and worst PaO2/FIO2 within 24 and 48 hours and
PaO2/FIO2 at 0, 6, 12, 18, 24, 36, and 48 hours after admission to
the ICU were collected. When blood gas analysis data at a specific
TABLE 1. Demographics of donors and recipients
Variable Data
Donor
Age, y (mean  SD) 36  16
Sex (F/M) 32/36
Cause of death, n (%)
Cerebral vascular accident 35 (51%)
Trauma 23 (34%)
Anoxic brain death 2 (3%)
Gunshot 4 (6%)
Other 4 (6%)
Smoking history, n (%)
None 28 (41%)
20 pack-y 29 (43%)
20 pack-y 7 (10%)
Unknown 4 (6%)
PaO2/FIO2 474  95
Recipient
Age, y (mean  SD) 37  14
Sex (F/M) 28/40
Underlying disease, n (%)
CF 41 (60%)
COPD 14 (21%)
ILD 7 (10%)
PH 6 (9%)
Preoperative high-risk status
Bipap use 10 (15%)
Hospitalization 13 (19%)
Cardiopulmonary bypass use 10 (15%)
Graft ischemic time (min) 431  135
SD, Standard deviation; PaO2 /FIO2 , arterial blood gas oxygen tension/
fraction of inspired oxygen ratio; CF, cystic fibrosis; COPD, chronic ob-
structive pulmonary disease; ILD, interstitial lung disease; PH, pulmonary
hypertension; Bipap, bilevel positive airway pressure support.time point were not available, then the data closest to the time
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blood gas result on FIO2  1.0 recorded at the time of donor
referral to the transplant center. The graft ischemic time of a
bilateral single-lung transplantation was defined as the ischemic
time for the second transplanted lungs in this study.
Assessment of Outcome of Early Graft Dysfunction
Duration of intubation, length of ICU stay, and 30-day mortality
were used as outcome indicators of early graft dysfunction.
Statistical Analysis
Analysis was performed with SAS version 8.2 (SAS Institute, Inc,
Cary, NC). Data were initially assessed for normality and were
log-transformed where appropriate. Duration of intubation and
length of ICU stay were both well approximated by a log-normal
distribution. Univariate analysis was performed on log-transformed
intubation time and log-transformed ICU stay by using Pearson
correlation coefficients for continuous variables and Student t tests
for binomial variables. Multivariate analysis for these 2 outcomes
was performed by using multiple linear regression. Univariate
analysis for 30-day mortality was performed by using 2 tests for182 The Journal of Thoracic and Cardiovascular Surgery ● Julyequal proportion and logistic regression. Multivariate analysis for
30-day mortality was conducted with multiple linear regression.
Time to death was further assessed by using Cox proportional
hazard regression for continuous variables and log-rank tests for
categorical variables. Multivariate models were constructed by
using a stepwise selection technique that considered all possible
prediction variables. Multivariate models were then validated with
a backward-elimination technique and further assessed for biolog-
ical and clinical plausibility. Continuous data were reported as
mean  standard deviation, whereas categorical data were re-
ported as count and proportions.
Results
From January 2000 to December 2002, a total of 68 bilateral
sequential lung transplantations were performed at the Al-
fred Hospital, and all of these were included in this study.
Donor and Recipient Demographics
The demographics of donors and recipients are summarized
in Table 1. Cerebrovascular accident (51%) was the most
Figure 2. Best and worst PaO2/FIO2 in
the first 24 and 48 hours after admis-
sion to the ICU.
Figure 1. Prevalence of various degrees of
PaO2/FIO2 versus time after admission to the
ICU.2005
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Ten percent of the donors had a smoking history of more
than 20 pack-years. With 1 exception, all donors had a
PaO2/FIO2 of more than 300 (mean, 474  95). Most recip-
ients had cystic fibrosis (60%), and the percentage of inter-
stitial lung disease and pulmonary hypertension was 10%
and 9%, respectively. Ten percent of the recipients had
cardiopulmonary bypass during transplantation.
Prevalence of PaO2/FIO2
The prevalence of various ranges of PaO2/FIO2 at 0, 6, 12,
18, 24, 36, and 48 hours after admission to the ICU is
depicted in Figure 1. A change in prevalence was seen from
0 to 12 hours. The prevalence of a PaO2/FIO2 less than 200
decreased in the range from 44% to 8%, whereas the prev-
alence of PaO2/FIO2 more than 300 increased in the range
from 33% to 67%. After 12 hours, the prevalence of PaO2/
FIO2 seemed stable. Figure 2 shows the best and worst
PaO2/FIO2 in the first 24 and 48 hours. A PaO2/FIO2 more
than 300 accounted for 85% of the best ratio of the first 24
hours; in contrast, it accounted for 18% of the worst ratio of
the 24 hours. A similar prevalence pattern was evident if the
best and worst ratios were viewed at 48 hours.
Correlation Analysis Between PaO2/FIO2 and Duration
of Intubation
A correlation analysis of PaO2/FIO2 in the first 24 hours with
respect to the natural log–transformed duration of intubation
is summarized in Table 2. The log-transformed data were
normally distributed. The PaO2/FIO2 at 12 hours best corre-
lated with intubation time (r  0.48; P  .001; Figure 3),
closely followed by PaO2/FIO2 at 6 hours (r  0.44; P 
.001).
Correlation Analysis Between PaO2/FIO2 and Length of
ICU Stay
The PaO2/FIO2 at 24 hours best correlated with the natural
TABLE 2. Pearson correlation analysis for duration of intu
Factor Correlation coefficient
PaO2/FIO2
0 h 0.27
6 h 0.44
12 h 0.48
18 h 0.30
24 h 0.37
Best in first 24 h 0.35
Worst in first 24 h 0.37
Other significant factors
CPB use 0.47
Donor smoking history 0.37
Donor PaO2/FIO2 0.29
PaO2 /FIO2 , Arterial blood gas oxygen tension/fraction of inspired oxygen rlog–transformed length of ICU stay (r  0.44; P  .001),
The Journal of Thoracifollowed by the PaO2/FIO2 at 6 hours (r  0.38; P  .002)
and 12 hours (r  0.36; P  .004; Table 3).
Correlation Analysis Between PaO2/FIO2 and 30-Day
Mortality
Seven patients (10%) died within 30 days after lung trans-
plantation in this series. PaO2/FIO2 at 6 hours was the only
significant factor related to 30-day mortality: those who
died had a significantly lower PaO2/FIO2 (219  93 vs 306
 101; P  .03).
Multivariate Regression Analysis
In the multivariate analysis, PaO2/FIO2 at 6 and 12 hours
was the strongest predictor of duration of intubation, and
PaO2/FIO2 at 6 and 24 hours was also the strongest pre-
dictor for length of ICU stay. All of these remained
statistically significant after adjusting for any potential
confounding effects.
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Figure 3. Correlation between log-transformed duration of intu-
bation and PaO2/FIO2 at 12 hours after admission to the ICU (black
circle indicates 30-day death; dotted lines indicate 95% confi-
n
95% CI F value P value
0.48 to 0.03 4.70 .034
0.62 to 0.21 14.57 .001
0.65 to 0.26 18.00 .001
0.52 to 0.05 5.82 .022
0.59 to 0.11 8.26 .007
0.55 to 0.11 8.76 .005
0.56 to 0.13 9.70 .003
0.25 to 0.64 17.62 .001
0.14 to 0.53 9.32 .003
0.49 to 0.04 5.68 .022
PB, cardiopulmonary bypass; CI, confidence interval.batiodence interval.)
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The percentage of patients not extubated versus time and the
percentage of patients staying in the ICU versus time sub-
grouped by the degree of PaO2/FIO2 at 6 hours were esti-
mated by the Kaplan-Meier method. There were significant
differences between the curves of subgroups in both intu-
bation time and ICU stay (Figure 4). Fifty-four percent of
the patients with PaO2/FIO2 at 6 hours less than 200 re-
mained intubated 48 hours after admission to the ICU and
also remained in the ICU 7 days after transplantation.
Discussion
We have described a detailed assessment of PaO2/FIO2 for
early graft dysfunction after lung transplantation. Different
definitions of outcome of early graft dysfunction using
variously classified variables, including the prevalence of
prolonged mechanical ventilation and ICU stay, chest ra-
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Figure 4. Percentage of patients not extubated and sta
TABLE 3. Pearson correlation analysis for length of ICU s
Factor Correlation coefficient
PaO2/FIO2
0 h 0.10
6 h 0.38
12 h 0.36
18 h 0.33
24 h 0.44
Best in first 24 h 0.27
Worst in first 24 h 0.33
Other significant factors
Donor smoking history 0.37
CPB use 0.36
Recipient age 0.25
ICU, Intensive care unit; PaO2 /FIO2 , arterial blood gas oxygen tension/fra
interval.method. Patients were subgrouped by the degree of PaO2/F
184 The Journal of Thoracic and Cardiovascular Surgery ● Julydiograph features, poor oxygenation results, and early mor-
tality, have been used in published studies.3-9 Unfortu-
nately, comparison with and between these other studies of
early graft dysfunction is difficult because of the lack of a
homogeneous definition. In this study, the continuous vari-
ables of duration of intubation and length of ICU stay and
the categorical variable of 30-day mortality were used as
alternative outcomes of early graft dysfunction to allow for
comparison with all prior definitions. PaO2/FIO2, a simple
parameter without any requirement for complicated meth-
ods in assessment and calculation, has been widely used for
assessing the graft function in lung transplantation3-9 and
for defining adult respiratory distress syndrome.10 Results
generally match those of this study: Thabut and colleagues5
reported that the worst PaO2/FIO2 within the first 3 postop-
erative days was associated with ICU mortality, and Chatila
and colleagues8 reported that the best PaO2/FIO2 in the first
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in the ICU versus time estimated by the Kaplan-Meier
95% CI F value P value
0.34 to 0.14 0.68 .411
0.57 to 0.15 10.39 .002
0.56 to 0.12 8.89 .004
0.54 to 0.08 7.08 .010
0.63 to 0.19 12.16 .001
0.48 to 0.02 4.74 .033
0.53 to 0.09 7.46 .008
0.14 to 0.57 10.17 .003
0.13 to 0.55 9.62 .003
0.01 to 0.46 4.23 .044
of inspired oxygen ratio; CPB, cardiopulmonary bypass; CI, confidenceyingtay
ctionIO2 at 6 hours after admission to the ICU.
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lation. Lee and colleagues9 reported that an immediate
postoperative PaO2/FIO2 of 200 correlated with an ICU
stay longer than 5 days. Christie and colleagues4 included
PaO2/FIO2 200 persisting beyond the first 48 hours in the
criteria for early graft dysfunction and found it to be asso-
ciated with prolonged mechanical ventilation and hospital
stay.
Although PaO2/FIO2 has been clarified to be a predictor
of early graft dysfunction, no information is available
regarding which measurement using PaO2/FIO2 best cor-
relates with early graft dysfunction. In this study, PaO2/
FIO2 at 6 and 12 hours after admission to the ICU was
independently and strongly associated with duration of
intubation, and PaO2/FIO2 at 6 and 24 hours was also
independently and strongly associated with the length of
ICU stay. A PaO2/FIO2 200 at 6 hours seemed to indi-
cate a prolonged duration of intubation and ICU stay
(Figure 3). The PaO2/FIO2 at 6 hours was not significant in
a final multivariate regression model for analysis of 30-
day mortality. It was a significant predictor in a univar-
iate model; however, the number of actual deaths was
small.
In a clinical situation, the availability of the markers
using PaO2/FIO2 at an earlier time point (such as 6 hours)
contributes to its usefulness beyond what is revealed by
the data at 12 and 24 hours, because this has the potential
to allow for earlier intervention for a specific group of
patients with early graft dysfunction. Therefore, PaO2/
FIO2 at 6 hours might be a more useful marker than that
at 12 or 24 hours.
The last donor PaO2/FIO2 before procurement was also
a significant factor associated with the duration of intu-
bation (Table 2). When we looked at the correlation
between donor and recipient PaO2/FIO2, donor PaO2/FIO2
best correlated with recipient PaO2/FIO2 at 0 hours (r 
0.54; P  .001). Although donor PaO2/FIO2 was associ-
ated with the graft oxygenation immediately after trans-
plantation and there was a general trend toward improved
graft function during the initial postoperative period up to
12 hours (Figure 1), exactly what transpires in that first
12 hours is still critical because PaO2/FIO2 at 12 hours
proved to best correlate with the duration of intubation.
Some possible limitations to this study should be
considered. First, ventilator settings potentially influ-
enced PaO2/FIO2; however, postoperative ventilatory
management was performed according to standard pro-
tocols, which generally aim toward the highest PaO2/FIO2
for minimum ventilator settings. An oxygen index [(mean
airway pressure  percentage of inspired oxygen)/partial
pressure of arterial oxygen] was reported to be useful for
predicting early outcomes after lung transplantation16
and to be worth further investigation. However, mean
The Journal of Thoraciairway pressure is not necessarily and easily calculated
by all ventilators, is not available on extubated patients,
and would not be applicable to single-lung transplanta-
tions (not addressed to this study). Second, most patients
did not have a complicated postoperative course and were
typically extubated on the second postoperative day.
Therefore, a spectrum of severity of early graft dysfunc-
tion, ranging from a mild form that was represented only
by subtle graft edema on chest radiograph to a severe
form that required prolonged mechanical ventilatory sup-
port, was included in this study. It may be relevant to
define only the more severe forms of early graft dysfunc-
tion. Third, we combined all causes of early graft dys-
function; however, contusion, clot, and cardiac dysfunc-
tion should possibly be removed to distinguish pure
primary graft failure.
Conclusion
Graft function, simply assessable via PaO2/FIO2, is a con-
stantly changing variable in the first 24 hours after lung
transplantation. Any definition of early graft dysfunction
(and its potential etiology and therapy) must consider this
variability. Although donor PaO2/FIO2 best correlates with
immediate graft function, subsequent traditional post–lung
transplantation outcomes (duration of intubation, length of
ICU stay, and 30-day survival) best correlate with PaO2/FIO2
6 to 12 hours after transplantation. There is the potential for
therapeutic interventions in the first 12 hours that can en-
hance the PaO2/FIO2 at 12 hours and improve subsequent
outcomes.
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